Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 3,307,610 7.463% | -841,036 (-20.27%) | Filing History |
| 2023-08-02 5:01 pm Sale | 2023-07-18 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 1,872,764 4.200% | -544,073 (-22.51%) | Filing History |
| 2023-07-05 4:17 pm Sale | 2023-06-28 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,416,837 5.500% | -543,394 (-18.36%) | Filing History |
| 2023-04-13 4:06 pm Sale | 2023-03-28 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,960,231 6.700% | -9,925 (-0.33%) | Filing History |
| 2023-02-16 4:40 pm Purchase | 2023-02-06 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 5,154,137 12.300% | 1,714,285 (+49.84%) | Filing History |
| 2023-02-16 4:05 pm Purchase | 2023-02-06 | 13G | Vera Bradley, Inc. VRA | Commodore Capital LP | 2,342,857 5.600% | 2,342,857 (New Position) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Vera Therapeutics, Inc. VERA | RA Capital Management, L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Vera Therapeutics, Inc. VERA | Citadel Advisors LLC | 1,991,553 7.200% | -50,867 (-2.49%) | Filing History |
| 2023-02-13 8:43 pm Purchase | 2023-02-06 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 3,477,081 8.300% | 285,714 (+8.95%) | Filing History |
| 2023-02-10 1:20 pm Purchase | 2022-12-30 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management, LP | 1,409,098 5.100% | 1,409,098 (New Position) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Vera Therapeutics, Inc. VERA | FMR LLC | 4,148,646 15.000% | 1,003,444 (+31.90%) | Filing History |
| 2023-02-03 7:07 pm Purchase | 2022-03-28 | 13D | Vera Therapeutics, Inc. VERA | Sofinnova Venture Partners X L.P. | 3,191,367 11.500% | 276,591 (+9.49%) | Filing History |
| 2023-02-03 5:22 pm Unchanged | 2022-12-31 | 13G | Vera Therapeutics, Inc. VERA | Kleiner Perkins Caufield & Byers XVI LLC | 1,343,152 4.900% | 0 (Unchanged) | Filing History |
| 2023-01-27 06:17 am Unchanged | 2022-12-31 | 13G | Vera Therapeutics, Inc. VERA | Ares Trading S.A. | 1,913,501 6.920% | 0 (Unchanged) | Filing History |
| 2022-08-11 5:01 pm Purchase | 2022-08-01 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,970,156 11.100% | 2,970,156 (New Position) | Filing History |
| 2022-04-07 4:39 pm Purchase | 2022-03-28 | 13D | Vera Therapeutics, Inc. VERA | Abingworth LLP | 2,970,156 11.100% | 9,925 (+0.34%) | Filing History |
| 2022-04-05 07:36 am Purchase | 2022-02-10 | 13D | Vera Therapeutics, Inc. VERA | Longitude Capital Partners IV LLC | 3,439,852 12.700% | 343,258 (+11.09%) | Filing History |
| 2022-02-24 4:30 pm Purchase | 2022-02-14 | 13G | Vera Therapeutics, Inc. VERA | RA Capital Management, L.P. | 2,000,000 7.500% | 2,000,000 (New Position) | Filing History |
| 2022-02-14 06:30 am Purchase | 2021-12-31 | 13G | Vera Therapeutics, Inc. VERA | Citadel Advisors LLC | 2,042,420 9.600% | 17,370 (+0.86%) | Filing History |
| 2022-02-11 4:51 pm Purchase | 2021-12-31 | 13G | Vera Therapeutics, Inc. VERA | Kleiner Perkins Caufield & Byers XVI LLC | 1,343,152 6.400% | 1,343,152 (New Position) | Filing History |